Aposense

  • Home
  • About Us
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    • Press release
    • Publications
  • Other Projects
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us


Apo-Si Nature deal makers – November 2017

10/29/2017

Read More

Publications
Aposense

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

Latest news

  • Notice: Convening of a Shareholders Meeting

    17 Sep 2018

  • The Company is pleased to announce the signing of a non-binding Term Sheet with Prof. Roger D. Kornberg, who was awarded the Nobel Prize in Chemistry in 2006 and is the Scientific President of the Company and Access Industries Inc for the formation of a joint venture. The joint venture will engage in the development and commercialization of products in the field of treatment of respiratory viral infections, based on the Apo-Si technology developed by the Company

    15 Aug 2018

  • EVENT: BIO INVESTOR Forum, October 17-18, San Francisco, California

    24 Sep 2017

Aposense © 2018. Privacy Policy
  • Home
  • About Us
    ▼
    • Our mission and vision
    • Scientific president
    • Team
    • Board of directors
    • Scientific advisory board
    • Intellectual property
  • Our Technology
  • Our Platform
  • Investors
    ▼
    • Presentations
    • Financial Reports
    • Stock Information
  • News Room
    ▼
    • Press release
    • Publications
  • Other Projects
    ▼
    • ATT-11T: Anti cancer pro-drug
    • ML-10
  • Contact Us